RMT (RMT) Stock Price & Analysis
RMT (RMT) fell 1.22% to USD 13.76 as of July 25, 2026 at 03:04 UTC, according to Nexqual real-time market data.
RMT last closed at USD 13.93; the session ranged USD 13.75–13.99 on volume of 128,293 shares. Market capitalization is $735.86M, with a 52-week range of USD 9.13–14.78 (NYQ). Source: Nexqual, July 25, 2026 at 03:04 UTC.
Key Statistics (as of July 25, 2026 at 03:04 UTC)
| Price | USD 13.76 |
|---|---|
| Change | ▼ 1.22% (down) |
| Previous Close | USD 13.93 |
| Open | USD 13.95 |
| Day Range | USD 13.75 – 13.99 |
| 52-Week Range | USD 9.13 – 14.78 |
| Volume | 128,293 shares |
| Market Cap | $735.86M |
| Exchange | NYQ |
Technical Analysis (RMT)
Nexqual's technical model rates RMT "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.69 (neutral) |
| vs SMA50 | Below (USD 13.94) |
| MACD | -0.02 (negative) |
Analyst Ratings (RMT)
Wall Street analysts rate RMT "None", per Nexqual as of July 25, 2026 at 03:04 UTC.
| Consensus Rating | None |
|---|
Earnings (RMT)
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financials & Fundamentals (RMT)
| Total Revenue | $4.92M |
|---|---|
| Revenue Growth (YoY) | -19.40% |
| Gross Margin | +100.00% |
| Operating Margin | -55.63% |
| Profit Margin | +1782.03% |
| ROE | +14.66% |
| Debt / Equity | 3.17 |
| Current Ratio | 0.54 |
| Total Cash | $38,529 |
| Total Debt | $20.00M |
| Free Cash Flow | $822,394 |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financial Health Score (RMT)
Nexqual rates RMT's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:04 UTC.
| Growth | Critical — Revenue -19% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $39K cash vs $20M debt |
| Cash Flow | Strong — FCF $822K, 17% margin |
| Efficiency | Mixed — ROE 15%, ROA -0.2% |
Ownership (RMT)
| Insider Ownership | +0.23% |
|---|---|
| Institutional Ownership | +37.88% |
| Shares Outstanding | 53.48M |
| Short % of Float | +0.07% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Leadership (RMT)
RMT is led by Charles Morgan Royce (age 85), Portfolio Manager and Chairman, per Nexqual as of July 25, 2026 at 03:04 UTC.
| Portfolio Manager and Chairman | Charles Morgan Royce (age 85) |
|---|
Major Backers & Investors (RMT)
Notable institutional backers of RMT include Saba Capital Management, L.P., Morgan Stanley, LPL Financial LLC, according to Nexqual as of July 25, 2026 at 03:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 5.64% |
| Morgan Stanley | 5% |
| LPL Financial LLC | 2.06% |
| Modern Wealth Management, LLC | 1.95% |
| Allspring Global Investments Holdings, LLC | 1.93% |
| Alexander Randolph Advisory, Inc. | 1.86% |
| RiverNorth Capital Management, LLC | 1.71% |
| UBS Group AG | 1.65% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RVT | Royce Value Trust, Inc. | USD 18.04 | ▼ 0.06% |
| ASG | Liberty All-Star Growth Fund, I | USD 5.07 | ▼ 1.36% |
| FUND | Sprott Focus Trust, Inc. - Clos | USD 9.81 | ▼ 0.51% |
| HQL | TeklaLife Sciences Investors | USD 19.25 | ▼ 2.38% |
| RFI | Cohen & Steers Total Return Rea | USD 11.7 | ▲ 2.54% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:04 UTC. This page is informational and not investment advice.